Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Susana Rives"'
Autor:
Águeda Molinos-Quintana, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero-Velázquez, Víctor Galán-Gómez, Melissa Panesso, Montserrat Torrebadell, Javier Delgado-Serrano, Concepción Pérez de Soto, Anna Faura, Berta González-Martínez, Ana Castillo-Robleda, Cristina Diaz-de-Heredia, Antonio Pérez-Martínez, José María Pérez-Hurtado, Susana Rives, José Antonio Pérez-Simón
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/4dbe78c098c647e1912ae1c76f51711c
Autor:
Edoardo Pennesi, Erica Brivio, Anneke C. J. Ammerlaan, Yilin Jiang, Vincent H. J. van der Velden, H. Berna Beverloo, Barbara Sleight, Franco Locatelli, Benoit Brethon, Claudia Rossig, Gernot Engstler, Anna Nilsson, Benedicte Bruno, Arnaud Petit, Bella Bielorai, Carmelo Rizzari, Fanny Rialland, Alba Rubio-San-Simón, Francisco J. Bautista Sirvent, Cristina Diaz-de-Heredia, Susana Rives, Christian M. Zwaan
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Inotuzumab Ozogamicin (InO) is a CD22-directed antibody conjugated with calicheamicin. The Phase 1B of the ITCC-059 trial tested InO combined with chemotherapy in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Relapsed /refractory
Externí odkaz:
https://doaj.org/article/c0f7af8ee2a94f19b2f8e805c1f3d42c
Autor:
Águeda Molinos-Quintana, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero-Velázquez, Víctor Galán-Gómez, Melissa Panesso, Montserrat Torrebadell, Javier Delgado-Serrano, Concepción Pérez de Soto, Anna Faura, Berta González-Martínez, Ana Castillo-Robleda, Cristina Diaz-de-Heredia, Antonio Pérez-Martínez, José María Pérez-Hurtado, Susana Rives, José Antonio Pérez-Simón
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
IntroductionLoss of B-cell aplasia (BCA) is a well-known marker of functional loss of CD19 CAR-T. Most relapses and loss of BCA occur in the first months after CD19 CAR-T infusion. In addition, high tumor burden (HTB) has shown to have a strong impac
Externí odkaz:
https://doaj.org/article/eab57116b92a4aee92a3c970d7151e29
Autor:
Pablo Velasco, Francisco Bautista, Alba Rubio, Yurena Aguilar, Susana Rives, Jose L. Dapena, Antonio Pérez, Manuel Ramirez, Cristina Saiz-Ladera, Elisa Izquierdo, Adela Escudero, Mireia Camós, Nerea Vega-García, Margarita Ortega, Gloria Hidalgo-Gómez, Carlos Palacio, Pablo Menéndez, Clara Bueno, Joan Montero, Paola A. Romecín, Santiago Zazo, Federico Alvarez, Juan Parras, Carmen Ortega-Sabater, Salvador Chulián, María Rosa, Davide Cirillo, Elena García, Jorge García, Albert Manzano-Muñoz, Alfredo Minguela, Jose L. Fuster
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with survival rates exceeding 85%. However, 15% of patients will relapse; consequently, their survival rates decrease to below 50%. Therefore, several research and innovation stu
Externí odkaz:
https://doaj.org/article/5124b9f3d98a4c79a13549557a869a45
Autor:
Peter Bader, Anna Alsonso, Andishe Attarbaschi, Nicole Bodmer, Halvard Bonig, Saskia Burridge, Jean-Pierre Bourquin, Veit Bücklein, Gunnar Cario, Macarena Oporto Espuelas, Tobias Feuhtinger, Anna Fuereder, Julia Hauer, Martin Hutter, Krzysztof Kałwak, Annette Künkele, Roland Meisel, Monika Mielcarek-Siedziuk, Ingo Müller, Sara Napolitano, Olaf Penack, Susana Rives, Claudia Rossig, Arend von Stackelberg, Andrea Jarisch, Sara Ghorashian, Adriana Balduzzi
Publikováno v:
HemaSphere, Vol 7, p e239539e (2023)
Externí odkaz:
https://doaj.org/article/0de9358a98e24532b581f74cf2758208
Autor:
Elena Esperanza Cebollada, Clara Vicente Garcés, Anna Alsonso, Esther Cuatrecasas Capdevila, Sandra Andreu, Alba Crespo Carrasco, Mercè Richarte, Sara Montesdeoca, Montserrat Torrebadell, Mireia Camos Guijosa, Susana Rives, Nerea Vega García
Publikováno v:
HemaSphere, Vol 7, p e664295d (2023)
Externí odkaz:
https://doaj.org/article/a3183b4af26d45b9886d1e581b6c225e
Autor:
Clara Vicente Garcés, Guerau Fernández, Elena Esperanza Cebollada, Susana Rives, Jose Luis Dapena, Mireia Camos Guijosa, Nerea Vega García
Publikováno v:
HemaSphere, Vol 7, p e51978b7 (2023)
Externí odkaz:
https://doaj.org/article/2baccc3bf0e34015aec6a99b3d15bfff
Autor:
Marina Caballero-Bellón, Anna Alonso-Saladrigues, Sara Bobillo-Perez, Anna Faura, Laura Arqués, Cristina Rivera, Albert Català, Jose Luis Dapena, Susana Rives, Iolanda Jordan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionChimeric antigen receptor (CAR)T-cell CD19 therapy is an effective treatment for relapsed/refractory B-cell acute lymphoblastic leukemia. It can be associated with life-threatening toxicities which often require PICU admission. Purpose: t
Externí odkaz:
https://doaj.org/article/98ca342b9c1b44b8aac013f40ff44801
Autor:
Susana Rives
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/fc6d25e2f36d428aad66365e5198e974
Autor:
Clara Vicente-Garcés, Joan Maynou, Guerau Fernández, Elena Esperanza-Cebollada, Montserrat Torrebadell, Albert Català, Susana Rives, Mireia Camós, Nerea Vega-García
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
RNA sequencing (RNA-seq) is a reliable tool for detecting gene fusions in acute leukemia. Multiple bioinformatics pipelines have been developed to analyze RNA-seq data, but an agreed gold standard has not been established. This study aimed to compare
Externí odkaz:
https://doaj.org/article/df8157a4ae75472f8546d2ee3c5bd548